|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Oxidoreductase
|
 |
|
Title:
|
 |
Ala177val mutant of e. Coli methylenetetrahydrofolate reductase complex with ly309887
|
|
Structure:
|
 |
5,10-methylenetetrahydrofolate reductase. Chain: a, b, c. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Escherichia coli. Organism_taxid: 562. Gene: metf. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.05Å
|
R-factor:
|
0.217
|
R-free:
|
0.250
|
|
|
Authors:
|
 |
R.Pejchal,E.Campbell,B.D.Guenther,B.W.Lennon,R.G.Matthews, M.L.Ludwig
|
Key ref:
|
 |
R.Pejchal
et al.
(2006).
Structural perturbations in the Ala --> Val polymorphism of methylenetetrahydrofolate reductase: how binding of folates may protect against inactivation.
Biochemistry,
45,
4808-4818.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Jan-06
|
Release date:
|
25-Apr-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C:
E.C.1.5.1.20
- Methylenetetrahydrofolate reductase (NAD(P)H).
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Folate Coenzymes
|
 |
 |
 |
 |
 |
Reaction:
|
 |
5-methyltetrahydrofolate + NAD(P)(+) = 5,10-methylenetetrahydrofolate + NAD(P)H
|
 |
 |
 |
 |
 |
5-methyltetrahydrofolate
|
+
|
NAD(P)(+)
|
=
|
5,10-methylenetetrahydrofolate
|
+
|
NAD(P)H
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
FAD
|
 |
 |
 |
 |
 |
FAD
Bound ligand (Het Group name =
FAD)
corresponds exactly
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
oxidation reduction
|
4 terms
|
 |
|
Biochemical function
|
oxidoreductase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
45:4808-4818
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural perturbations in the Ala --> Val polymorphism of methylenetetrahydrofolate reductase: how binding of folates may protect against inactivation.
|
|
R.Pejchal,
E.Campbell,
B.D.Guenther,
B.W.Lennon,
R.G.Matthews,
M.L.Ludwig.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
In human methylenetetrahydrofolate reductase (MTHFR) the Ala222Val (677C-->T)
polymorphism encodes a heat-labile gene product that is associated with elevated
levels of homocysteine and possibly with risk for cardiovascular disease.
Generation of the equivalent Ala to Val mutation in Escherichia coli MTHFR,
which is 30% identical to the catalytic domain of the human enzyme, creates a
protein with enhanced thermolability. In both human and E. coli MTHFR, the A -->
V mutation increases the rate of dissociation of FAD, and in both enzymes, loss
of FAD is linked to changes in quaternary structure [Yamada, K., Chen, Z.,
Rozen, R., and Matthews, R. G. (2001) Proc. Natl. Acad. Sci. U.S.A. 98,
14853-14858; Guenther, B. D., Sheppard, C. A., Tran, P., Rozen, R., Matthews, R.
G., and Ludwig, M. L. (1999) Nat. Struct. Biol. 6, 359-365]. Folates have been
shown to protect both human and bacterial enzymes from loss of FAD. Despite its
effect on affinity for FAD, the A --> V mutation is located at the bottom of the
(betaalpha)(8) barrel of the catalytic domain in a position that does not
contact the bound FAD prosthetic group. Here we report the structures of the
Ala177Val mutant of E. coli MTHFR and of its complex with the 5,10-dideazafolate
analogue, LY309887, and suggest mechanisms by which the mutation may perturb FAD
binding. Helix alpha5, which immediately precedes the loop bearing the mutation,
carries several residues that interact with FAD, including Asn168, Arg171, and
Lys172. In the structures of the mutant enzyme this helix is displaced,
perturbing protein-FAD interactions. In the complex with LY309887, the
pterin-like ring of the analogue stacks against the si face of the flavin and is
secured by hydrogen bonds to residues Gln183 and Asp120 that adjoin this face.
The direct interactions of bound folate with the cofactor provide one mechanism
for linkage between binding of FAD and folate binding that could account in part
for the protective action of folates. Conformation changes induced by folate
binding may also suppress dissociation of FAD.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.Ciccimaro,
and
I.A.Blair
(2010).
Stable-isotope dilution LC-MS for quantitative biomarker analysis.
|
| |
Bioanalysis, 2,
311-341.
|
 |
|
|
|
|
 |
M.N.Lee,
D.Takawira,
A.P.Nikolova,
D.P.Ballou,
V.C.Furtado,
N.L.Phung,
B.R.Still,
M.K.Thorstad,
J.J.Tanner,
and
E.E.Trimmer
(2009).
Functional role for the conformationally mobile phenylalanine 223 in the reaction of methylenetetrahydrofolate reductase from Escherichia coli.
|
| |
Biochemistry, 48,
7673-7685.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.W.Cheng,
J.C.Yu,
C.S.Huang,
J.C.Shieh,
Y.P.Fu,
H.W.Wang,
P.E.Wu,
and
C.Y.Shen
(2008).
Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan.
|
| |
Breast Cancer Res Treat, 111,
145-155.
|
 |
|
|
|
|
 |
V.M.Guillem,
M.Collado,
M.J.Terol,
M.J.Calasanz,
J.Esteve,
M.Gonzalez,
C.Sanzo,
J.Nomdedeu,
P.Bolufer,
A.Lluch,
and
M.Tormo
(2007).
Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies.
|
| |
Leukemia, 21,
1413-1422.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|